scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Jagsonpal Pharmaceuticals Ltd

Feedback
Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 102,476
Mar 28, 2025 15:51 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹217.20
₹-5.30 (-2.38%)
₹215.05 Low
Today’s Performance
₹225.1 High
₹109.44 Low
52 Week’s Performance
₹328.04 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -2.38%
  • 1 Week -0.34%
  • 1 Month 3.80%
  • 3 Months -13.04%
  • 6 Months 34.18%
  • 1 Year 98.17%
  • 3 Years 25.96%
  • 5 Years 98.39%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 2.00
  • Beta 1.61
  • 52-Week Low (₹) 109.44
  • 52-Week High (₹) 328.04
  • Price-to-Book (X)* 7.54
  • Dividend Yield (%) 0.89
  • Price-to-Earnings (P/E) (X)* 28.40
  • Earnings Per Share (₹) 7.88
  • Sector Price Earning (X)* 34.00
  • Market Cap (₹ Cr.)* 1,477.11
  • * Vaues as of last close price

COMPETITORS

BT TV

Arvind Virmani On India-US Trade And Supply Chains 12:20 Arvind Virmani On India-US Trade And Supply Chains
Puneet Chhatwal On IHCL’s Claridges Expansion In Lutyens’ Delhi 2:13 Puneet Chhatwal On IHCL’s Claridges Expansion In Lutyens’ Delhi
'Strict Action Against Threats, No Room For Unrest' : Amit Shah On Immigration Bill 1:52 'Strict Action Against Threats, No Room For Unrest' : Amit Shah On Immigration Bill
Inside Uber’s Hybrid Network | Autonomous Cars + Human Drivers | Uber's Sachin Kansal Exclusive 12:07 Inside Uber’s Hybrid Network | Autonomous Cars + Human Drivers | Uber's Sachin Kansal Exclusive
Trump’s 25% Auto Tariff: Opportunity Or Crisis For India? 2:33 Trump’s 25% Auto Tariff: Opportunity Or Crisis For India?
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Feb 25, 2022 Sell
J & P INVESTMENTS PARTNERSHIP
  • Qty 225737
  • Average Price ₹239.32
Feb 25, 2022 PURCHASE
MANISH MAHESH GUPTA
  • Qty 225067
  • Average Price ₹239.32
Feb 24, 2022 PURCHASE
MANISH MAHESH GUPTA
  • Qty 200433
  • Average Price ₹235.33
Feb 24, 2022 Sell
J & P INVESTMENTS PARTNERSHIP
  • Qty 199763
  • Average Price ₹235.33
Feb 22, 2022 PURCHASE
NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 187783
  • Average Price ₹231.51
Feb 22, 2022 PURCHASE
RAJASTHAN GLOBAL SECURITIES PVT LTD
  • Qty 440659
  • Average Price ₹228.00
Feb 22, 2022 Sell
XTX MARKETS LLP
  • Qty 137115
  • Average Price ₹231.75
Feb 22, 2022 Sell
NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 187911
  • Average Price ₹231.63
Feb 22, 2022 Sell
RAJASTHAN GLOBAL SECURITIES PVT LTD
  • Qty 140000
  • Average Price ₹245.06
Feb 22, 2022 PURCHASE
XTX MARKETS LLP
  • Qty 142145
  • Average Price ₹231.33
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Jagsonpal Pharmaceuticals Ltd share price previously?
Jagsonpal Pharmaceuticals Ltd share price was down by -2.38% from the previous closing price of ₹222.50.
Who are peers of Jagsonpal Pharmaceuticals Ltd?
The peers of Jagsonpal Pharmaceuticals Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Jagsonpal Pharmaceuticals Ltd?
The promotor/promotors of Jagsonpal Pharmaceuticals Ltd are Manish Gupta, Harsha Raghavan, Debasis Bikash Nandy, Radhika Dudhat, Pallavi Dinodia, Prithipal Singh Kochhar.
What has been 52-week high of Jagsonpal Pharmaceuticals Ltd stocks?
The highest price of Jagsonpal Pharmaceuticals Ltd stock is ₹328.04 in the last 52-week.
What is the share price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) today on NSE?
As on Mar 28, 2025, Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)’s share price on NSE is Rs 217.2
What is the market cap of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM?)
The current market capitalisation of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is 1,477.11 crores
What is Jagsonpal Pharmaceuticals Ltd Share symbol?
The symbol of Jagsonpal Pharmaceuticals Ltd is JAGSNPHARM.
What is the PE ratio of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)?
The current PE ratio of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is 28.40.
What is the PB ratio of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)?
The current PB ratio of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is 7.54.
Today’s High & Low share prices of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) on NSE?
Today, the share price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) on NSE touched a high of Rs 225.1 and a low of Rs 215.05
What price did Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) shares open on the NSE today?
On NSE, the share price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) opened at Rs 223
What is the 52-week high of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)?
The 52-week high price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is Rs 328.04
What is the 52-week low of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) ?
The 52-week low price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is Rs 109.44

ABOUT JAGSONPAL PHARMA

Jagsonpal Pharmaceuticals Ltd, incorporated in the year 1978, has its registered office in T-210 J, Shahpur Jat, New Delhi, New Delhi, 110049, 91-011-46181100/46109900, 91-011-26498341. The main industry in which Jagsonpal Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Jagsonpal Pharmaceuticals Ltd is/are Walker Chandiok & Co LLP. In the main management, Harsha Raghavan is chairman and is the company secretary for Jagsonpal Pharmaceuticals Ltd.

  • MG Manish Gupta Managing Director
  • HR Harsha Raghavan Chairman & Non Executive Dir.
  • DBN Debasis Bikash Nandy Independent Director
  • RD Radhika Dudhat Independent Director
  • PD Pallavi Dinodia Independent Director
  • PSK Prithipal Singh Kochhar Non Executive Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement